For example, miR-668 inhibits MTP18 to prevent excessive mitochondrial fission and protect tubular cells from apoptosis during ischemic injury [81,82], whereas miR-17 downregulates PPAR-α, impairing mitochondrial energy metabolism and promoting cyst formation in polycystic kidney disease [83]. Here, PPARA is linked to polycystic kidney disease.